Ilan Neugarten joined the Viola Group in 2000 as a partner of DOR Ventures, a VC fund focusing on imaging technologies. During his period at DOR Ventures
he led various investments including medical imaging ventures.
Prior to DOR Ventures, Ilan spent 20 years at Scitex holding a variety of positions, Including General Manager of the Print On-Demand Solutions Division
and General Manager of Scitex Japan KK and a board member of Nihon Scitex Ltd. He led growth from $30 million in revenue to $105 million and concluded the largest Scitex OEM sale, valued at $55 million (to NTT). As part of his tenure in Scitex and Dor Ventures, Ilan has gained considerable experience in the medical device industry. Ilan managed the Viola Group medical device investment program.
In this capacity he identified and led investments in early stage Israeli medical device companies.
Currently he serves as the executive Chairman of Rainbow Medical innovation and investment house.
Ilan received his BSc in electronics from the Technion and MBA from Boston University.